MHRA approves Marinus Pharmaceuticals’ Ztalmy for CDKL5 deficiency disorder by Jen Brogan | Mar 8, 2024 | News | 0 The rare epileptic seizure disorder currently affects around one in 42,000 people in the UK Read More